All Idis articles
-
Business
Merger creates biggest supplier of unlicensed drugs
Clinigen will buy Idis to consolidate different routes by which doctors can access medicines that are unavailable locally
2015-05-27T00:00:00Z
It’s been an interesting month in the world of off-label pharmaceuticals
2015-05-05T00:00:00Z
Clinigen will buy Idis to consolidate different routes by which doctors can access medicines that are unavailable locally
Site powered by Webvision Cloud